Correction to: Pediatric Cardiology https://doi.org/10.1007/s00246-022-02930-z

The conflict of interest statement is missed to include in the original article.

The conflict of interest statement is given below:

Dr. Goldberg is a named inventor on method of use patents regarding the use of udenafil in patients who have undergone Fontan palliation.

Dr. Rychik is a consultant for Mezzion Pharmaceuticals, a company in search of solutions for challenges in the single ventricle population.

The original article has been corrected.